Oruka Therapeutics, Inc. (ORKA)
93.55
+1.35
(+1.46%)
USD |
NASDAQ |
Sep 16, 16:00
93.61
+0.06
(+0.06%)
After-Hours: 20:00
Oruka Therapeutics Shareholders Equity (Quarterly) : 1.115B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.115B |
| March 31, 2026 | 486.72M |
| December 31, 2025 | 471.93M |
| September 30, 2025 | 486.79M |
| June 30, 2025 | 343.64M |
| March 31, 2025 | 364.72M |
| December 31, 2024 | 382.22M |
| September 30, 2024 | 395.21M |
| June 30, 2024 | 32.57M |
| March 31, 2024 | 35.12M |
| December 31, 2023 | 37.02M |
| September 30, 2023 | 37.97M |
| June 30, 2023 | 39.24M |
| March 31, 2023 | 40.53M |
| December 31, 2022 | 41.67M |
| September 30, 2022 | 42.73M |
| June 30, 2022 | 44.96M |
| March 31, 2022 | 47.94M |
| December 31, 2021 | 51.04M |
| September 30, 2021 | 56.60M |
| June 30, 2021 | 61.21M |
| March 31, 2021 | 65.91M |
| December 31, 2020 | 46.52M |
| September 30, 2020 | 50.46M |
| June 30, 2020 | 10.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.306M |
| December 31, 2019 | 7.61M |
| September 30, 2019 | 8.799M |
| June 30, 2019 | 9.189M |
| March 31, 2019 | 7.318M |
| December 31, 2018 | 6.032M |
| September 30, 2018 | 7.463M |
| June 30, 2018 | 8.998M |
| March 31, 2018 | 11.05M |
| December 31, 2017 | 10.28M |
| September 30, 2017 | 14.35M |
| June 30, 2017 | 14.75M |
| March 31, 2017 | 18.04M |
| December 31, 2016 | 22.19M |
| September 30, 2016 | 26.48M |
| June 30, 2016 | 30.89M |
| March 31, 2016 | 34.58M |
| December 31, 2015 | 38.07M |
| September 30, 2015 | 41.09M |
| June 30, 2015 | 43.76M |
| March 31, 2015 | 12.13M |
| December 31, 2014 | 14.74M |
| September 30, 2014 | 17.20M |
| June 30, 2014 | 19.32M |
| March 31, 2014 | 21.53M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 113.59M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 0.977M |
| Century Therapeutics, Inc. | 232.34M |
| Absci Corp. | 246.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.139B |
| Total Liabilities (Quarterly) | 24.84M |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 38.51 |
| Net Debt Paydown Yield | -0.01% |